TNF and rheumatoid arthritis: In November 1998, the US the first Food and Drug Administration (FDA) authorized Etanercept, the first anti- tumor necrosis factor inhibitors (TNFi), for the treatment of moderate to severe rheumatoid arthritis (RA) (217).